This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.68% per year. These returns cover a period from January 1, 1988 through August 5, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Is HMS Holdings (HMSY) Stock Outpacing Its Medical Peers This Year?
by Zacks Equity Research
Is (HMSY) Outperforming Other Medical Stocks This Year?
Medical Product's Q4 Earnings on Feb 24: VWR, SARTF, HMSY
by Zacks Equity Research
Let's take a look at the major Medical Product stocks slated to release their fourth-quarter 2016 numbers on Feb 24.
IRADIMED (IRMD) MRidium Magnetic MRI Gets FDA Approval
by Zacks Equity Research
IRADIMED CORPORATION (IRMD) recently announced the receipt of 510(k) clearance for its MRidium 3860+ magnetic MRI compatible IV infusion pump system, which features the Dose Error Reduction System software (DERS).
TransEnterix (TRXC) Opens New Surgical Robotics Facility
by Zacks Equity Research
TransEnterix (TRXC) announced that it would open a new surgical robotics facility in Milan, Italy.
Stryker (SYK) to Pay for Rejuvenate and ABG II Modular-Neck
by Zacks Equity Research
Stryker Corporation (SYK) announced that it has reached an agreement to compensate patients for Rejuvenate and ABG II Modular-Neck surgeries done prior to Dec 19, 2016.
Masimo's (MASI) TFA-1 Forehead Sensor Gets FDA Approval
by Zacks Equity Research
Masimo Corporation (MASI) recently announced that its TFA-1 Single-Patient-Use Adhesive Forehead Sensor has received a 5I0(k) clearance from the U.S. FDA.
PharMerica Amends Credit Facility, Ups Borrowing Capacity
by Zacks Equity Research
PharMerica Corporation (PMC) announced that it has amended its existing credit agreement.
Varian Expands in Croatia with Edge Radiosurgery Product
by Zacks Equity Research
Varian Medical Systems, Inc. (VAR) announced that its flagship product Edge Radiosurgery system is being installed at Croatia-based Radiochirurgia Zagreb Clinic.
Pacific Biosciences Terminates SMRT Agreement with Roche
by Zacks Equity Research
Pacific Biosciences of California, Inc. (PACB), announced that F. Hoffman-La Roche Ltd has chosen to terminate a preexisting development, commercialization and license agreement.
St. Jude Medical (STJ): EnSite Precision Gets FDA Clearance
by Zacks Equity Research
St. Jude Medical Inc. (STJ), a leading global medical device manufacturer, recently announced U.S. FDA approval for the EnSite Precision cardiac mapping system and Advisor FL Circular Mapping Catheter.
Baxter (BAX) to Acquire India-Based Claris Injectables
by Zacks Equity Research
Baxter International Inc. (BAX), a global medical technology company, has signed a definitive agreement to acquire Claris Lifesciences Limited???s subsidiary Claris Injectables Limited for almost $625 million.
St. Jude Medical: Proclaim Elite SCS System Now CE Marked
by Zacks Equity Research
St. Jude Medical Inc. (STJ), a leading global medical device manufacturer recently announced the CE mark approval for the full-body magnetic resonance (MR) conditional labeling of the Proclaim Elite Spinal Cord Stimulation (SCS) System.
Merit Medical Hits 52-Week High: What's Driving the Stock?
by Zacks Equity Research
Share price of South Jordan, Utah-based Merit Medical Systems, Inc. (MMSI) reached a fresh 52-week high of $26.80 on Dec 9, finally closing a tad lower at $26.60.
West Pharma (WST) Hits 52-Week High on Growth Prospects
by Zacks Equity Research
Shares of West Pharmaceutical Services, Inc. (WST) reached a new 52-week high of $84.21 on Friday, Dec 9, 2016.
The Cooper Companies (COO) Beats Q4 Earnings Estimates
by Zacks Equity Research
The Cooper Companies Inc. (COO) reported adjusted earnings of $2.28 in fourth-quarter 2016, surpassing the Zacks Consensus Estimate by 4 cents and improving 14% on a year-over-year basis.
Integer (ITGR) to Co-Develop CCM Therapy with Impulse Dynamics
by Zacks Equity Research
Integer Holdings Corporation (ITGR) announced that it has signed a development agreement with Impulse Dynamics.
Ecolab (ECL) Rewards Shareholders with 6% Dividend Hike
by Zacks Equity Research
Ecolab Inc. (ECL) declared a quarterly cash dividend of 37 cents per share, reflecting a 6% increase from the previous payout.
ABIOMED Impella CP Gets Expanded FDA Approval, Stock Up
by Zacks Equity Research
Danvers, MA-based ABIOMED, Inc. (ABMD), a leading medical product developer, announced the expanded U.S. FDA pre-market approval (PMA) for the usage of Impella CP heart pump.
Inogen (INGN) Affirms Outlook and Shuffles Top Management
by Zacks Equity Research
Inogen, Inc. (INGN) reiterated its fiscal 2016 outlook and appointed a new President cum Chief Executive Officer.
CryoLife (CRY) Now a Strong Buy: Should You Add the Stock?
by Zacks Equity Research
On Dec 6, Kennesaw, GA-based CryoLife Inc. (CRY) was raised to a Zacks Rank #1 (Strong Buy).
athenahealth-ADP Launch Cloud-Based Payroll for Hospitals
by Zacks Equity Research
athenahealth Inc (ATHN) recently introduced cloud-based payroll and attendance services for small hospitals in collaboration with Automatic Data Processing (ADP).
Varian (VAR) in Just 100 List from JUST Capital and Forbes
by Zacks Equity Research
Varian Medical Systems Inc. (VAR) announced it was included in the inaugural JUST 100 List.
Veeva Systems Set to Grow on Subscription Revenue Focus
by Zacks Equity Research
On Nov 30, we issued an updated research report on Pleasanton, CA-based Veeva Systems Inc. (VEEV).
TrovaGene Inks Contract with Boreal Genomics, Stock Down
by Zacks Equity Research
TrovaGene Inc. (TROV), a molecular diagnostic company, recently announced the signing of a long-term Supply and Distribution Agreement with Boreal Genomics.
Patterson Companies: Q2 Results Dismal, Forex a Concern
by Zacks Equity Research
On Nov 30, we issued an updated research report on St. Paul, MN-based Patterson Companies Inc. (PDCO) ??? a leading distributor of dental and animal health products.